[
GSK sells worldwide rights for linerixibat to Alfasigma for $300m
[og_img]
https://www.investing.com/news/stock-market-news/gsk-sells-worldwide-rights-for-linerixibat-to-alfasigma-for-300m-93CH-4548764
Investing.com
GSK sells worldwide rights for linerixibat to Alfasigma for $300m
Related articles




